Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Frydendals Dyreklinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   4.2% 2.7% 2.0% 1.2% 1.7% 1.2% 12.0% 12.0%   Credit score (0-100)   50 61 68 80 72 80 20 20   Credit rating   BBB BBB A A A A BB BB   Credit limit (kDKK)   0.0 0.0 0.2 45.4 1.7 63.5 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,417 1,888 2,313 2,440 2,634 3,205 0.0 0.0   EBITDA   239 378 915 683 369 580 0.0 0.0   EBIT   90.1 223 695 449 118 400 0.0 0.0   Pre-tax profit (PTP)   48.0 188.9 692.9 445.2 113.7 399.9 0.0 0.0   Net earnings   36.2 144.8 538.9 345.7 84.7 308.7 0.0 0.0   Pre-tax profit without non-rec. items   48.0 189 693 445 114 400 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,036 1,072 991 758 540 360 0.0 0.0   Shareholders equity total   89.0 234 773 1,118 1,203 1,512 1,462 1,462   Interest-bearing liabilities   1,072 695 152 180 134 77.0 0.0 0.0   Balance sheet total (assets)   1,704 1,739 2,310 2,008 2,139 2,415 1,462 1,462   Net Debt   941 543 -369 -351 -581 -733 -1,462 -1,462     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,417 1,888 2,313 2,440 2,634 3,205 0.0 0.0   Gross profit growth   69.4% 33.2% 22.5% 5.5% 8.0% 21.7% -100.0% 0.0%   Employees   3 4 3 4 6 7 0 0   Employee growth %   0.0% 33.3% -25.0% 33.3% 50.0% 16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,704 1,739 2,310 2,008 2,139 2,415 1,462 1,462   Balance sheet change%   16.1% 2.0% 32.9% -13.1% 6.5% 12.9% -39.5% 0.0%   Added value   238.7 378.4 914.6 683.1 351.7 580.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -111 -119 -301 -467 -468 -360 -360 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   6.4% 11.8% 30.0% 18.4% 4.5% 12.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.7% 13.0% 34.3% 20.8% 5.7% 17.6% 0.0% 0.0%   ROI %   7.5% 20.0% 69.1% 38.0% 8.6% 27.1% 0.0% 0.0%   ROE %   51.1% 89.7% 107.1% 36.6% 7.3% 22.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   5.2% 13.5% 33.5% 55.7% 56.3% 62.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   394.3% 143.5% -40.4% -51.3% -157.5% -126.3% 0.0% 0.0%   Gearing %   1,204.5% 297.1% 19.6% 16.1% 11.1% 5.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.9% 3.9% 0.5% 2.5% 2.8% 1.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.3 0.7 1.1 1.4 1.8 0.0 0.0   Current Ratio   0.4 0.5 0.9 1.5 1.8 2.2 0.0 0.0   Cash and cash equivalent   130.9 151.9 521.0 531.0 714.6 809.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -884.4 -758.0 -140.0 422.9 697.8 1,072.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   80 95 305 171 59 83 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   80 95 305 171 61 83 0 0   EBIT / employee   30 56 232 112 20 57 0 0   Net earnings / employee   12 36 180 86 14 44 0 0